🇧🇪 Belgium Country × Condition
multiple myeloma Clinical Trials in Belgium
Active clinical trials for multiple myeloma with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇧🇪 Belgium
Active Trials in Belgium (2)
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Enrollment
387 pts
Country
🇧🇪 Belgium
Regeneron Pharmaceuticals
View Trial → NCT06953960 Phase 1, Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Enrollment
130 pts
Country
🇧🇪 Belgium
AbbVie
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Belgium?
There are currently 2 active clinical trials for multiple myeloma with sites in Belgium, of which 2 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Belgium?
To join a multiple myeloma clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Belgium?
Active multiple myeloma trials in Belgium span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.